Login Register Cart 0
Generic placeholder image

The Natural Products Journal

Editor-in-Chief

ISSN (Print): 2210-3155
ISSN (Online): 2210-3163

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Current Development and Application on Inclusion of Herbal Phytochemicals in Novel Herbal Drug Delivery System

Author(s): Aziz Ahmed*, Rizwan Ahmad, Shurbhi Jangir and Deeksha Sharma

Volume 15, Issue 1, 2025

Published on: 25 March, 2024

Article ID: e250324228308 Pages: 12

DOI: 10.2174/0122103155281428240320091344

Price: $65

Abstract

Herbal phytochemicals as secondary metabolites are present in herbal medicines. Herbal medicines can be used to treat a wide range of illnesses and diseases. The Novel herbal drug delivery system approach includes transfersomes, ethosomes, microspheres, phytosomes, liposomes, polymeric nanoparticles, and nanocapsules. The novel herbal drug delivery systems have several benefits over conventional herbal remedies. Herbal medicines are less expensive and have fewer serious side effects than generic medications. The novel herbal drug delivery systems have several benefits over conventional herbal remedies. These include improved solubility and bioavailability, protection from side effects, improved pharmacological action, increased stability, better delivery to tissue macrophages, consistent delivery, and defense against active ingredients' physical and chemical breakdown. There is a need for a novel method of active components of drugs to apply on target organs or sites of the human body to avoid repeated administration of dosage forms and enhance patient adherence. Scientists have tried to focus on advanced mechanisms or processes for delivering herbal components into the human body. Novel Herbal Drug Delivery System helps to boost drug efficacy by lessening side effects and enhancing the blood level of the drug. Novel herbal formulations can reduce recurrent administration of medicines and noncompliance of patients.

[1]
Kunle, O.F.; Egharevba, H.O.; Ahmadu, P.O. Standardization of herbal medicines –A review. J. Biodivers. Conserv., 2012, 4(3), 101-112.
[2]
Barboza, G.E.; Cantero, J.J.; Núñez, C.; Pacciaroni, A.; Espinar, L.A. Medicinal plants: A general review and a phytochemical and ethnopharmacological screening of the native Argentine Flora. Kurtziana, 2009, 34, 7-365.
[3]
Wachtel-Galor, S.; Benzie, I.F.F. Herbal medicine.In: Biomolecular and Clinical Aspects, 2nd ed; CRC Press/Taylor & Francis: Boca Raton, 2011.
[4]
Pal, S.K.; Shukla, Y. Herbal medicine: Current status and the future. Asian Pac. J. Cancer Prev., 2003, 4(4), 281-288.
[PMID: 14728584]
[5]
WHO Traditional medicine strategy: 2014-2023. Hong Kong, SAR; World Health Organization: China, 2013.
[6]
Tilburt, J.; Kaptchuk, T.J. Herbal medicine research and global health: an ethical analysis. Bull. World Health Organ., 2008, 86(8), 594-599.
[http://dx.doi.org/10.2471/BLT.07.042820] [PMID: 18797616]
[7]
Kamboj, A. Analytical evaluation of herbal drugs. In: Drug discovery research in Pharmacognosy, 1st ed; Tech Publication: Rijeka, Croatia, 2012.
[http://dx.doi.org/10.5772/26109]
[8]
Balunas, M.J.; Kinghorn, A.D. Drug discovery from medicinal plants. Life Sci., 2005, 78(5), 431-441.
[http://dx.doi.org/10.1016/j.lfs.2005.09.012] [PMID: 16198377]
[9]
Butler, M.S. The role of natural product chemistry in drug discovery. J. Nat. Prod., 2004, 67(12), 2141-2153.
[http://dx.doi.org/10.1021/np040106y] [PMID: 15620274]
[10]
Guidelines for the regulation of herbal medicines in the South-East Asia Region; World Health Organization: New Delhi, 2004.
[11]
Krishnaiah, Y.S.R. Pharmaceutical technologies for enhancing oral bioavailability of poorly soluble drugs. J. Bioequivalence Bioavailab., 2010, 2(2), 28-36.
[http://dx.doi.org/10.4172/jbb.1000027]
[12]
Teeranachaideekul, V.; Müller, R.; Junyaprasert, V. Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)—Effects of formulation parameters on physicochemical stability. Int. J. Pharm., 2007, 340(1-2), 198-206.
[http://dx.doi.org/10.1016/j.ijpharm.2007.03.022] [PMID: 17482778]
[13]
Siddiqui, I.A.; Sanna, V. Impact of nanotechnology on the delivery of natural products for cancer prevention and therapy. Mol. Nutr. Food Res., 2016, 60(6), 1330-1341.
[http://dx.doi.org/10.1002/mnfr.201600035] [PMID: 26935239]
[14]
Aqil, F.; Munagala, R.; Jeyabalan, J.; Vadhanam, M.V. Bioavailability of phytochemicals and its enhancement by drug delivery systems. Cancer Lett., 2013, 334(1), 133-141.
[http://dx.doi.org/10.1016/j.canlet.2013.02.032] [PMID: 23435377]
[15]
Adhami, V.M.; Mukhtar, H. Human cancer chemoprevention: Hurdles and challenges. Top. Curr. Chem., 2012, 329, 203-220.
[http://dx.doi.org/10.1007/128_2012_342] [PMID: 22790416]
[16]
Nikam, P.; Jain, A.; Solanki, D.; Aher, S. Revolutionizing pharmaceuticals: A deep dive into self-nano emulsifying drug delivery systems. Int. J. Curr. Pharm. Res., 2024, 16(1), 1-9.
[http://dx.doi.org/10.22159/ijcpr.2024v16i1.4019]
[17]
Vargason, A.M.; Anselmo, A.C.; Mitragotri, S. The evolution of commercial drug delivery technologies. Nat. Biomed. Eng., 2021, 5(9), 951-967.
[http://dx.doi.org/10.1038/s41551-021-00698-w] [PMID: 33795852]
[18]
Stephen, C. Bacteriophages as nanocarriers for targeted drug delivery and enhanced therapeutic effects. Mater. Adv., 2024, 5, 986-1016.
[19]
Medina, O.; Zhu, Y.; Kairemo, K. Targeted liposomal drug delivery in cancer. Curr. Pharm. Des., 2004, 10(24), 2981-2989.
[http://dx.doi.org/10.2174/1381612043383467] [PMID: 15379663]
[20]
Singh, H.; Sharma, G. Recent development of novel drug delivery of herbal drugs. RPS Pharmacy and Pharmacology Reports, 2023, 2, rqad028.
[http://dx.doi.org/10.1093/rpsppr/rqad028]
[21]
Jain, S.; Kirar, M.; Bindeliya, M.; Sen, L.; Soni, M.; Shan, M.; Purohit, A.; Jain, P.K. Novel drug delivery systems: An overview. AJDHS, 2022, 2(1), 33-39.
[http://dx.doi.org/10.22270/ajdhs.v2i1.14]
[22]
Bent, S. Herbal medicine in the United States: Review of efficacy, safety, and regulation: Grand rounds at University of California, san francisco medical center. J. Gen. Intern. Med., 2008, 23(6), 854-859.
[http://dx.doi.org/10.1007/s11606-008-0632-y] [PMID: 18415652]
[23]
Calixto, J.B. Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents). Braz. J. Med. Biol. Res., 2000, 33(2), 179-189.
[http://dx.doi.org/10.1590/S0100-879X2000000200004] [PMID: 10657057]
[24]
Saxena, M.; Saxena, J.; Nema, R.; Singh, D.; Gupta, A. Phytochemistry of medicinal plants. J. Pharmacogn. Phytochem., 2013, 1(6), 168-182.
[25]
Hasler, C.M.; Blumberg, J.B. Symposium on phytochemicals: Biochemistry and physiology.J. Nutr; , 1999, 129, pp. 756-757.
[26]
Ndhlala, A.R.; Stafford, G.I.; Finnie, J.F.; Van Staden, J. Commercial herbal preparations in KwaZulu-Natal, South Africa: The urban face of traditional medicine. S. Afr. J. Bot., 2011, 77(4), 830-843.
[http://dx.doi.org/10.1016/j.sajb.2011.09.002]
[27]
Cano, J.H.; Volpato, G. Herbal mixtures in the traditional medicine of Eastern Cuba. J. Ethnopharmacol., 2004, 90(2-3), 293-316.
[http://dx.doi.org/10.1016/j.jep.2003.10.012] [PMID: 15013195]
[28]
Harborne, J.B. Phytochemical Methods a Guide to Modern Techniques of Plant Analysis; Chapman and Hall Ltd: London, 1973.
[29]
Kauri, R.; Arora, S. Alkaloids-important therapeutic secondary metabolites of plant origin. J. Crit. Rev., 2015, 2(3), 1-8.
[30]
Güçlü-Üstündağ, Ö.; Mazza, G. Saponins: Properties, applications and processing. Crit. Rev. Food Sci. Nutr., 2007, 47(3), 231-258.
[http://dx.doi.org/10.1080/10408390600698197] [PMID: 17453922]
[31]
Chung, K.T.; Wong, T.Y.; Wei, C.I.; Huang, Y.W.; Lin, Y. Tannins and human health: A review. Crit. Rev. Food Sci. Nutr., 1998, 38(6), 421-464.
[http://dx.doi.org/10.1080/10408699891274273] [PMID: 9759559]
[32]
Kumar, S.; Pandey, A.K. Chemistry and biological activities of flavonoids: An overview. ScientificWorldJournal, 2013, 2013, 1-16.
[http://dx.doi.org/10.1155/2013/162750] [PMID: 24470791]
[33]
Patel, D.K.; Kumar, R.; Laloo, D.; Hemalatha, S. Natural medicines from plant source used for therapy of diabetes mellitus: An overview of its pharmacological aspects. Asian Pac. J. Trop. Dis., 2012, 2(3), 239-250.
[http://dx.doi.org/10.1016/S2222-1808(12)60054-1]
[34]
Wassie, S.M.; Aragie, L.L.; Taye, B.W.; Mekonnen, L.B. Knowledge, attitude, and utilization of traditional medicine among the communities of Merawi town, Northwest Ethiopia: A cross-sectional study. Evid. Based Complement. Alternat. Med., 2015, 2015, 1-7.
[http://dx.doi.org/10.1155/2015/138073] [PMID: 26508974]
[35]
Mhame, P. the role of traditional knowledge (TK) in the National Economy: the importance and scope of TK, particularly traditional medicine in Tanzania In: UNCTAD Expert Meeting on Systems and National Experiences for Protecting Traditional Knowledge, Innovations and Practices; Geneva, 2000.
[36]
WHO Traditional Medicine Strategy 2002-2005; Geneva 2002.
[37]
Maroyi, A. Traditional use of medicinal plants in south-central Zimbabwe: Review and perspectives. J. Ethnobiol. Ethnomed., 2013, 9(1), 31.
[http://dx.doi.org/10.1186/1746-4269-9-31] [PMID: 23642285]
[38]
Pandey, M.M.; Rastogi, S.; Rawat, A.K.S. Indian traditional ayurvedic system of medicine and nutritional supplementation. Evid. Based Complement. Alternat. Med., 2013, 2013, 1-12.
[http://dx.doi.org/10.1155/2013/376327] [PMID: 23864888]
[39]
Qazi, M.A.; Molvi, K. Herbal medicine: A comprehensive review. J. Pharm. Res., 2016, 8(2), 1-5.
[40]
Barnes, P.M.; Bloom, B. Complementary and alternative medicine use among adults and children: United States, 2007. Natl. Health Stat. Report., 2007, 10(12), 1-23.
[41]
Borokini, T.I.; Omotayo, F.O. Phytochemical and ethnobotanical study of some selected medicinal plants from Nigeria. J. Med. Plants Res., 2012, 6(7), 1106-1118.
[http://dx.doi.org/10.5897/JMPR09.430]
[42]
Koehn, F.E.; Carter, G.T. The evolving role of natural products in drug discovery. Nat. Rev. Drug Discov., 2005, 4(3), 206-220.
[http://dx.doi.org/10.1038/nrd1657] [PMID: 15729362]
[43]
Williamson, E. Synergy and other interactions in phytomedicines. Phytomedicine, 2001, 8(5), 401-409.
[http://dx.doi.org/10.1078/0944-7113-00060] [PMID: 11695885]
[44]
Raskin, I.; Ripoll, C. Can an apple a day keep the doctor away? Curr. Pharm. Des., 2004, 10(27), 3419-3429.
[http://dx.doi.org/10.2174/1381612043383070] [PMID: 15544525]
[45]
Gómez Castellanos, J.R.; Prieto, J.M.; Heinrich, M. Red Lapacho (Tabebuia impetiginosa)—A global ethnopharmacological commodity? J. Ethnopharmacol., 2009, 121(1), 1-13.
[http://dx.doi.org/10.1016/j.jep.2008.10.004] [PMID: 18992801]
[46]
Cravotto, G.; Boffa, L.; Genzini, L.; Garella, D. Phytotherapeutics: An evaluation of the potential of 1000 plants. J. Clin. Pharm. Ther., 2010, 35(1), 11-48.
[http://dx.doi.org/10.1111/j.1365-2710.2009.01096.x] [PMID: 20175810]
[47]
Schmidt, B.; Ribnicky, D.M.; Poulev, A.; Logendra, S.; Cefalu, W.T.; Raskin, I. A natural history of botanical therapeutics. Metabolism, 2008, 57(7)(Suppl. 1), S3-S9.
[http://dx.doi.org/10.1016/j.metabol.2008.03.001] [PMID: 18555851]
[48]
Lila, M.A.; Raskin, I. Health-related Interactions of phytochemicals. J. Food Sci., 2005, 70(1), R20-R27.
[http://dx.doi.org/10.1111/j.1365-2621.2005.tb09054.x]
[49]
Capasso, R.; Aviello, G.; Borrelli, F.; Romano, B.; Ferro, M.; Castaldo, L.; Montanaro, V.; Altieri, V.; Izzo, A.A. Inhibitory effect of standardized Cannabis sativa extract and its ingredient cannabidiol on rat and human bladder contractility. Urology, 2011, 77(4), 1006.e9-1006.e15.
[http://dx.doi.org/10.1016/j.urology.2010.12.006] [PMID: 21310467]
[50]
De Smet, P.A.G.M. Herbal remedies. N. Engl. J. Med., 2002, 347(25), 2046-2056.
[http://dx.doi.org/10.1056/NEJMra020398] [PMID: 12490687]
[51]
Nortier, J.L.; Martinez, M.C.M.; Schmeiser, H.H.; Arlt, V.M.; Bieler, C.A.; Petein, M.; Depierreux, M.F.; De Pauw, L.; Abramowicz, D.; Vereerstraeten, P.; Vanherweghem, J.L. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N. Engl. J. Med., 2000, 342(23), 1686-1692.
[http://dx.doi.org/10.1056/NEJM200006083422301] [PMID: 10841870]
[52]
Stickel, F.; Patsenker, E.; Schuppan, D. Herbal hepatotoxicity. J. Hepatol., 2005, 43(5), 901-910.
[http://dx.doi.org/10.1016/j.jhep.2005.08.002] [PMID: 16171893]
[53]
Shekelle, P.G.; Hardy, M.L.; Morton, S.C.; Maglione, M.; Mojica, W.A.; Suttorp, M.J.; Rhodes, S.L.; Jungvig, L.; Gagné, J. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: A meta-analysis. JAMA, 2003, 289(12), 1537-1545.
[http://dx.doi.org/10.1001/jama.289.12.1537] [PMID: 12672771]
[54]
Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk. Final rule. Fed. Regist., 2004, 69(28), 6787-6854.
[PMID: 14968803]
[55]
Hoffman, B.B.; Taylor, P. Neurotransmission.In: Goodman and Gilman’s The Pharmacological Basis of Therapeutics. 10; Hardman, J.G.; Limbird, L.E., Eds.; McGrawHill: New York, NY, 2001, pp. 115-153.
[56]
Habeck, M.; Benowitz, N.L.; Jacob, P., III Diabetes treatments get sweet help from nature. Nat. Med., 2003, 9(10), 1228.
[http://dx.doi.org/10.1038/nm1003-1228a] [PMID: 14520349]
[57]
Morris, C.A.; Avorn, J. Internet marketing of herbal products. JAMA, 2003, 290(11), 1505-1509.
[http://dx.doi.org/10.1001/jama.290.11.1505] [PMID: 13129992]
[58]
Larsen, H.O.; Olsen, C.S. Unsustainable collection and unfair trade? Uncovering and assessing assumptions regarding Central Himalayan medicinal plant conservation. Biodivers. Conserv., 2007, 16(6), 1679-1697.
[http://dx.doi.org/10.1007/s10531-006-9039-4]
[59]
Baker, D.D.; Chu, M.; Oza, U.; Rajgarhia, V. The value of natural products to future pharmaceutical discovery. Nat. Prod. Rep., 2007, 24(6), 1225-1244.
[http://dx.doi.org/10.1039/b602241n] [PMID: 18033577]
[60]
Chan, K.; Shaw, D.; Simmonds, M.S.J.; Leon, C.J.; Xu, Q.; Lu, A.; Sutherland, I.; Ignatova, S.; Zhu, Y.P.; Verpoorte, R.; Williamson, E.M.; Duez, P. Good practice in reviewing and publishing studies on herbal medicine, with special emphasis on traditional Chinese medicine and Chinese materia medica. J. Ethnopharmacol., 2012, 140(3), 469-475.
[http://dx.doi.org/10.1016/j.jep.2012.01.038] [PMID: 22330011]
[61]
Muchugi, A.; Muluvi, G.M.; Kindt, R.; Kadu, C.A.C.; Simons, A.J.; Jamnadass, R.H. Genetic structuring of important medicinal species of genus Warburgia as revealed by AFLP analysis. Tree Genet. Genomes, 2008, 4(4), 787-795.
[http://dx.doi.org/10.1007/s11295-008-0151-3]
[62]
Makunga, N.P.; Philander, L.E.; Smith, M. Current perspectives on an emerging formal natural products sector in South Africa. J. Ethnopharmacol., 2008, 119(3), 365-375.
[http://dx.doi.org/10.1016/j.jep.2008.07.020] [PMID: 18703128]
[63]
Semwal, D.P.; Saradhi, P.P.; Nautiyal, B.P.; Bhatt, A.B. Current status, distribution and conservation of rare and endangered medicinal plants of Kedarnath Wildlife Sanctuary, Central Himalayas, India. Curr Sci India., 2007, 92, 1733-1738.
[64]
Ma, J.; Rong, K.; Cheng, K. Research and practice on biodiversity in situ conservation in China: Progress and prospect. Shengwu Duoyangxing, 2012, 20, 551-558.
[65]
Madni, A.; Rahim, M.A.; Mahmood, M.A.; Jabar, A.; Rehman, M.; Shah, H.; Khan, A.; Tahir, N.; Shah, A. Enhancement of dissolution and skin permeability of pentazocine by proniosomes and niosomal gel. AAPS PharmSciTech, 2018, 19(4), 1544-1553.
[http://dx.doi.org/10.1208/s12249-018-0967-6] [PMID: 29470828]
[66]
Ahmad, M.Z.; Mohammed, A.A.; Mokhtar Ibrahim, M. Technology overview and drug delivery application of proniosome. Pharm. Dev. Technol., 2017, 22(3), 302-311.
[http://dx.doi.org/10.3109/10837450.2015.1135344] [PMID: 26794727]
[67]
Prasad, N.S. Augmentation of dissolution profile of poorly soluble Olmesartan medoximil formulating into pronisomes. European JBPS, 2016, 3(2), 122-128.
[68]
Bonifácio, B.V.; Silva, P.B.; Ramos, M.A.; Negri, K.M.S.; Bauab, T.M.; Chorilli, M. Nanotechnology-based drug delivery systems and herbal medicines: A review. Int. J. Nanomedicine, 2014, 9, 1-15.
[PMID: 24363556]
[69]
Sharma, M. Applications of nanotechnology based dosage forms for delivery of herbal drugs. Research and Reviews. J. Pharm. Nanotechnol., 2014, 2(1), 23-30.
[70]
Li, D.C.; Zhong, X.K.; Zeng, Z.P.; Jiang, J.G.; Li, L.; Zhao, M.M.; Yang, X.Q.; Chen, J.; Zhang, B.S.; Zhao, Q.Z.; Xie, M.Y.; Xiong, H.; Deng, Z.Y.; Zhang, X.M.; Xu, S.Y.; Gao, Y.X. Application of targeted drug delivery system in Chinese medicine. J. Control. Release, 2009, 138(2), 103-112.
[http://dx.doi.org/10.1016/j.jconrel.2009.05.008] [PMID: 19433120]
[71]
Hong, W.; Chen, D.W.; Zhao, X.L.; Qiao, M.X.; Hu, H.Y. Preparation and study in vitro of long-circulating nanoliposomes of curcumin. Zhongguo Zhongyao Zazhi, 2008, 33(8), 889-892.
[PMID: 18619344]
[72]
Wen, Z.; Liu, B.; Zheng, Z.; You, X.; Pu, Y.; Li, Q. Preparation of liposomes entrapping essential oil from Atractylodes macrocephala Koidz by modified RESS technique. Chem. Eng. Res. Des., 2010, 88(8), 1102-1107.
[http://dx.doi.org/10.1016/j.cherd.2010.01.020]
[73]
Sun, P.; Den, S.H.; Yu, W.P. Evaluation of garlicin liposomes. J Shan Univ TCM, 2007, 31, 37-39.
[74]
Gupta, V.K.; Karar, P.K.; Ramesh, S.; Misra, S.P.; Gupta, A. Nanoparticle formulation for hydrophilic and hydrophobic drugs. Int J Res Pharm Sci, 2010, 1, 163-169.
[75]
Lira, M.C.B.; Ferraz, M.S.; Silva, D.G.V.C.; Cortes, M.E.; Teixeira, K.I.; Caetano, N.P.; Sinisterra, R.D.; Ponchel, G.; Santos-Magalhães, N.S. Inclusion complex of usnic acid with β-cyclodextrin: Characterization and nanoencapsulation into liposomes. J. Incl. Phenom. Macrocycl. Chem., 2009, 64(3-4), 215-224.
[http://dx.doi.org/10.1007/s10847-009-9554-5]
[76]
Dwivedi, C.; Verma, S. Review on preparation and characterization of liposomes with application. J. Scientific & Innov. Res., 2013, 2, 486-508.
[77]
Asijia, R. Development of proniosomes gel as a drug carrier for transdermal delivery of acyclovir. J. Drug Deliv. Ther., 2014, 2(18), 41-51.
[78]
Jain, N.; Gupta, B.P.; Thakur, N.; Jain, R.; Banweer, J.; Jain, D.; Jain, S. Phytosome: A novel drug delivery system for herbal medicine. Int. J. Pharm. Sci. Drug Res., 2010, 2(4), 224-228.
[79]
Yanyu, X.; Yunmei, S.; Zhipeng, C.; Qineng, P. The preparation of silybin–phospholipid complex and the study on its pharmacokinetics in rats. Int. J. Pharm., 2006, 307(1), 77-82.
[http://dx.doi.org/10.1016/j.ijpharm.2005.10.001] [PMID: 16300915]
[80]
Maiti, K.; Mukherjee, K.; Gantait, A.; Bishnu, P.S.; Mukherjee, P.K. Enhanced therapeutic potential of naringenin-phospholipid complex in rats. J. Pharm. Pharmacol., 2006, 58, 1227-1233.
[http://dx.doi.org/10.1211/jpp.58.9.0009] [PMID: 16945181]
[81]
Maiti, K.; Mukherjee, K.; Gantait, A.; Ahamed, H.N.; Saha, B.P.; Mukherjee, P.K. Enhanced therapeutic benefit of quercetin – Phospholipid complex in carbon tetrachloride–induced acute liver injury in rats: A comparative study. Iran J Pharmacol Ther, 2005, 4, 84-90.
[82]
Maiti, K.; Mukherjee, K.; Gantait, A.; Saha, B.P.; Mukherjee, P.K. Curcumin–phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats. Int. J. Pharm., 2007, 330(1-2), 155-163.
[http://dx.doi.org/10.1016/j.ijpharm.2006.09.025] [PMID: 17112692]
[83]
Bhattacharya, S. Phytosomes: Emerging strategy in delivery of herbal drugs and nutraceuticals. Pharm. Times, 2009, 41, 9-12.
[84]
Panda, V.S.; Naik, S.R. Cardioprotective activity of Ginkgo biloba Phytosomes in isoproterenol-induced myocardial necrosis in rats: A biochemical and histoarchitectural evaluation. Exp. Toxicol. Pathol., 2008, 60(4-5), 397-404.
[http://dx.doi.org/10.1016/j.etp.2008.03.010] [PMID: 18513933]
[85]
Kareparamban, J.A.; Nikam, P.H.; Jadhav, P.A.; Kadam, V.J. Phytosome: A novel revolution in herbal drugs. Int. J. Res. Pharm. Chem., 2012, 2(2), 299-310.
[86]
Deshpande, P.K.; Pathak, A.P.; Gothalwal, R. Phytosomes: A novel drug delivery system for phytoconstituents. J. New Biol. Rep., 2014, 3(3), 212-220.
[87]
Mamillapalli, V.; Atmakuri, A.M.; Khantamneni, P. Nanoparticles for herbal extracts. Asian J. Pharm., 2016, 10(2), 54-60.
[88]
Abirami, A.; Halith, S.M.; Pillai, K.K.; Anbalagan, C. Herbal nanoparticle for anticancer potential- A review. World J. Pharm. Pharm. Sci., 2014, 3(8), 2123-2132.
[89]
Shimada, S. Composition comprising nanoparticle ginkgo biloba extract with the effect of brain function activation. U.S. Patent 20080254126A1, 2008.
[90]
Min, K.H.; Park, K.; Kim, Y.S.; Bae, S.M.; Lee, S.; Jo, H.G.; Park, R.W.; Kim, I.S.; Jeong, S.Y.; Kim, K.; Kwon, I.C. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. J. Control. Release, 2008, 127(3), 208-218.
[http://dx.doi.org/10.1016/j.jconrel.2008.01.013] [PMID: 18336946]
[91]
Mukerjee, A.; Vishwanatha, J.K. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anticancer Res., 2009, 29(10), 3867-3875.
[PMID: 19846921]
[92]
Feng-Lin, Y.; Tzu-Hui, W.; Liang-Tzung, L.; Thau-Ming, C.; Chun-Ching, L. Naringenin-loaded nanoparticles improve the physicochemical properties and the hepatoprotective effects of naringenin in orally-administered rats with CCl(4)-induced acute liver failure. Pharm. Res., 2009, 26(4), 893-902.
[http://dx.doi.org/10.1007/s11095-008-9791-0] [PMID: 19034626]
[93]
Lertsutthiwong, P.; Noomun, K.; Jongaroonngamsang, N.; Rojsitthisak, P.; Nimmannit, U. Preparation of alginate nanocapsules containing turmeric oil. Carbohydr. Polym., 2008, 74(2), 209-214.
[http://dx.doi.org/10.1016/j.carbpol.2008.02.009]
[94]
Liu, M.; Li, H.; Luo, G.; Liu, Q.; Wang, Y. Pharmacokinetics and biodistribution of surface modification polymeric nanoparticles. Arch. Pharm. Res., 2008, 31(4), 547-554.
[http://dx.doi.org/10.1007/s12272-001-1191-8] [PMID: 18449515]
[95]
Tzu-Hui, W.; Feng-Lin, Y.; Liang-Tzung, L.; Tong-Rong, T.; Chun-Ching, L.; Thau-Ming, C. Preparation, physicochemical characterization, and antioxidant effects of quercetin nanoparticles. Int. J. Pharm., 2008, 346(1–2), 160-168.
[PMID: 17689897]
[96]
Hou, J.; Zhou, S.W. ACTA Academiae medicinae militaris tertiae, 2008, 30, 1043-1048.
[97]
Li, Y.C.; Dong, L.; Jia, K.; Chang, X.M.; Xue, H. Xi’an Jiaotong University. Med. Sci., 2007, 28, 517-520.
[98]
Youfang, C.; Xianfu, L.; Hyunjin, P.; Richard, G. Study of artemisinin nanocapsules as anticancer drug delivery systems. Nanomedicine , 2009, 5(3), 316-322.
[PMID: 19523432]
[99]
Alsarra, A. Proniosomes as a drug carrier for transdermal delivery of ketorolac. Eur. J. Pharm. Biopharm., 2004, 105, 1-6.
[PMID: 15760729]
[100]
Şanlı, O.; Karaca, İ.; Işıklan, N. Preparation, characterization, and salicylic acid release behavior of chitosan/poly(vinyl alcohol) blend microspheres. J. Appl. Polym. Sci., 2009, 111(6), 2731-2740.
[http://dx.doi.org/10.1002/app.29319]
[101]
Xiao, L.; Zhang, Y.H.; Xu, J.C.; Jin, X.H. Preparation of floating rutin-alginate-chitosan microcapsule. Chin. Tradit. Herbal Drugs, 2008, 2, 209-212.
[102]
You, J.; Cui, F.; Han, X.; Wang, Y.; Yang, L.; Yu, Y.; Li, Q. Study of the preparation of sustained-release microspheres containing zedoary turmeric oil by the emulsion–solvent-diffusion method and evaluation of the self-emulsification and bioavailability of the oil. Colloids Surf. B Biointerfaces, 2006, 48(1), 35-41.
[http://dx.doi.org/10.1016/j.colsurfb.2005.12.011] [PMID: 16480856]
[103]
Machida, Y.; Onishi, H.; Kurita, A.; Hata, H.; Morikawa, A.; Machida, Y. Pharmacokinetics of prolonged-release CPT-11-loaded microspheres in rats. J. Control. Release, 2000, 66(2-3), 159-175.
[http://dx.doi.org/10.1016/S0168-3659(99)00267-9] [PMID: 10742577]
[104]
Chao, P.; Deshmukh, M.; Kutscher, H.L.; Gao, D.; Rajan, S.S.; Hu, P.; Laskin, D.L.; Stein, S.; Sinko, P.J. Pulmonary targeting microparticulate camptothecin delivery system: anticancer evaluation in a rat orthotopic lung cancer model. Anticancer Drugs, 2010, 21(1), 65-76.
[http://dx.doi.org/10.1097/CAD.0b013e328332a322] [PMID: 19966540]
[105]
Yadav, M.; Bhatia, V.J.; Doshi, G.; Shastri, K. Novel techniques in herbal drug delivery systems. Int. J. Pharm. Sci. Rev. Res., 2014, 28(2), 83-89.
[106]
Fatima, G.X.; Rahul, R.S.; Reshma, I.; Sandeep, T.; Shanmuganathan, S.; Chamundeeswari, D. Herbal ethosomes - A novel approach in herbal drug technology. American J. Ethonomedicine., 2014, 1(4), 226-230.
[107]
Ajazuddin, S.; Saraf, S. Applications of novel drug delivery system for herbal formulations. Fitoterapia, 2010, 81(7), 680-689.
[http://dx.doi.org/10.1016/j.fitote.2010.05.001] [PMID: 20471457]
[108]
Sachan, R.; Parashar, T. A drug carrier transferosomes: A novel tool for transdermal drug delivery system. IJRDPL, 2013, 2(2), 309-316.
[109]
Long, X.Y.; Luo, J.B.; Li, L.R.; Lin, D.; Rong, H.S.; Huang, W.M. Preparation and in vitro evaluations of topically applied capsaicin transfersomes. Zhongguo Zhongyao Zazhi, 2006, 31(12), 981-984.
[PMID: 17048643]
[110]
Singh, H.P.; Utreja, P.; Tiwary, A.K.; Jain, S. Elastic liposomal formulation for sustained delivery of colchicine: in vitro characterization and in vivo evaluation of anti-gout activity. AAPS J., 2009, 11(1), 54-64.
[http://dx.doi.org/10.1208/s12248-008-9078-8] [PMID: 19191031]
[111]
Zhaowu, Z.; Xiaoli, W.; Yangde, Z.; Nianfeng, L. Preparation of matrine ethosome, its percutaneous permeation in vitro and anti-inflammatory activity in vivo in rats. J. Liposome Res., 2009, 19(2), 155-162.
[http://dx.doi.org/10.1080/08982100902722381] [PMID: 19241204]
[112]
Paolino, D.; Lucania, G.; Mardente, D.; Alhaique, F.; Fresta, M. Ethosomes for skin delivery of ammonium glycyrrhizinate: In vitro percutaneous permeation through human skin and in vivo anti inflammatory activity. J. Control. Release, 2005, 106(1-2), 99-110.
[113]
Ma, B.; Duan, X.; Wang, Z. Clinical and experimental study on Shuanghua aerosol in treating infantile upper respiratory tract infection. Chung Kuo Chung Hsi I Chieh Ho Tsa Chih, 2000, 20(9), 653-655.
[PMID: 11789167]
[114]
Jadhav, V.; Bhogale, V. Novel drug delivery system in herbal. Int. J. Pharm. Wave., 2015, 1(2), 85-103.
[115]
Pascoa, H.; Diniz, D.G.A.; Florentino, I.F.; Costa, E.A.; Bara, M.T.F. Microemulsion based on Pterodon emarginatus oil and its anti-inflammatory potential. Braz. J. Pharm. Sci., 2015, 51(1), 117-125.
[http://dx.doi.org/10.1590/S1984-82502015000100013]
[116]
Lu, M.F.; Cheng, Y.Q.; Li, L.J.; Wu, J.J. Progress of study on passive targeting of drug delivery system. Mater Rev, 2005, 19, 108-110.
[117]
Zhou, X.; Li, L.Y.; Guo, Z.J. Application of targeted drug delivery system in chinese medicine. Linchuang Zhongliuxue Zazhi, 2004, 9, 229-234.
[118]
Mei, Z.; Chen, H.; Weng, T.; Yang, Y.; Yang, X. Solid lipid nanoparticle and microemulsion for topical delivery of triptolide. Eur. J. Pharm. Biopharm., 2003, 56(2), 189-196.
[http://dx.doi.org/10.1016/S0939-6411(03)00067-5] [PMID: 12957632]
[119]
Li, L.; Wang, D.K.; Li, L.S.; Jia, J.; Chang, D.; Ai, L. Preparation of docetaxel submicron emulsion formation for intravenous administration. J. Shenyang Pharm. Univ., 2007, 12, 736-739.
[120]
Sun, H.W.; Ouyang, W.Q. Preparation, quality and safety evaluation of berbarine nano emulsion for oral application. J. Shanghai Jiaotong Univ., 2007, 1, 60-65.
[121]
Tangri, P.; Khurana, S. Niosomes: Formulation and evaluation. Int J Biopharm, 2011, 2, 47-53.
[122]
Gupta, S.; Singh, R.P.; Lokwani, P.; Yadav, S.; Gupta, S.K. Vesicular system as targeted drug delivery system: An overview. Int J Pharm Technol, 2011, 3, 987-1021.
[123]
Shukla, N.D.; Tiwari, M. Proniosomal drug delivery systems – Clinical applications. Int. J. Res. Pharm. Biomed. Sci., 2011, 2, 880-887.
[124]
Goyal, C.; Ahuja, M.; Sharma, S.K. Preparation and evaluation of anti-inflammatory activity of gugulipid-loaded proniosomal gel. Acta Pol. Pharm., 2011, 68(1), 147-150.
[PMID: 21485714]
[125]
Raja, K.; Ukken, J.P.; Athul, P.V.; Tamizharasi, S.; Sivakumar, T. Formulation and evaluation of maltodextrin based proniosomal drug delivery system containing anti-diabetic (glipizide) drug. Int. J. Pharm. Tech. Res., 2011, 3, 471-477.

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy